BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Glebe D. Recent advances in hepatitis B virus research: A German point of view. World J Gastroenterol 2007; 13(1): 8-13 [PMID: 17206750 DOI: 10.3748/wjg.v13.i1.8]
URL: https://www.wjgnet.com/1007-9327/full/v13/i1/8.htm
Number Citing Articles
1
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Hong-Ying Chen, Lan Yu, Bao-Zhang Tang, Jun-Hua Huang. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis BWorld Journal of Gastroenterology 2008; 14(7): 1112-1119 doi: 10.3748/wjg.14.1112
2
Alexander K. Andrianov, Daniel P. DeCollibus, Helice A. Gillis, Henry H. Kha, Alexander Marin, Mark R. Prausnitz, Lorne A. Babiuk, Hugh Townsend, George Mutwiri. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunizationProceedings of the National Academy of Sciences 2009; 106(45): 18936 doi: 10.1073/pnas.0908842106
3
Siyu Li, Na Li, Shanru Yang, Haiyan Deng, Yanguo Li, Yixuan Wang, Jiaqiang Yang, Jiaxin Lv, Lan Dong, Guansen Yu, Xin Hou, Geng Wang. The study of immune checkpoint inhibitors in chronic hepatitis B virus infectionInternational Immunopharmacology 2022; 109: 108842 doi: 10.1016/j.intimp.2022.108842
4
AmirReza Hesari, Faezeh Ghasemi, Reza Salarinia, Hamed Biglari, Agheel Tabar Molla Hassan, Vali Abdoli, Hamed Mirzaei. Effects of curcumin on NF‐κB, AP‐1, and Wnt/β‐catenin signaling pathway in hepatitis B virus infectionJournal of Cellular Biochemistry 2018; 119(10): 7898 doi: 10.1002/jcb.26829
5
David S. Goodsell. The Molecular Perspective: Hepatitis B VirusThe Oncologist 2007; 12(5): 516 doi: 10.1634/theoncologist.12-5-516
6
Meilong Shen, Shixia Wang, Guohong Ge, Yiping Xing, Xiuwen Ma, Zuhu Huang, Shan Lu. Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigenVaccine 2010; 28(45): 7288 doi: 10.1016/j.vaccine.2010.08.081
7
Haotian Yu, Zhaohua Hou, Qiuju Han, Cai Zhang, Jian Zhang. The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-αVirology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-270
8
Yang-Xia Li, Yan-Li Ren, Hai-Jing Fu, Ling Zou, Ying Yang, Zhi Chen, Isabelle A Chemin. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent MannerPLOS ONE 2016; 11(7): e0159089 doi: 10.1371/journal.pone.0159089
9
Xingfei Pan, Ka Zhang, Xiaoan Yang, Jiayi Liang, Haixia Sun, Xuejun Li, Yong Zou, Qingqiang Xu, Geng An, Gang Li, Qihuan Xu, Matti Sällberg. Relapse Rate and Associated-Factor of Recurrence after Stopping NUCs Therapy with Different Prolonged Consolidation Therapy in HBeAg Positive CHB PatientsPLoS ONE 2013; 8(7): e68568 doi: 10.1371/journal.pone.0068568
10
Yajing Liu, Yanfang Zhao, Xin Zhai, Xiuping Liu, Lixue Sun, Yanxia Ren, Ping Gong. Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐Imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in vitroArchiv der Pharmazie 2008; 341(7): 446 doi: 10.1002/ardp.200800035
11
Dieter Glebe, Andreas Geipel. Selected Phenotypic Assays Used to Evaluate Antiviral Resistance and Viral Fitness of Hepatitis B Virus and Its VariantsIntervirology 2014; 57(3-4): 225 doi: 10.1159/000360950
12
Mengxin Lin, Ruyi Guo, Cuiping Ma, Dawu Zeng, Zhijun Su. Manganese Breaks the Immune Tolerance of HBs-AgOpen Forum Infectious Diseases 2021; 8(2) doi: 10.1093/ofid/ofab028
13
María L. Cuestas, Verónica L. Mathet, José R. Oubiña, Alejandro Sosnik. Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) InfectionPharmaceutical Research 2010; 27(7): 1184 doi: 10.1007/s11095-010-0112-z
14
Karina Scaramuzzi, Denise Cristina André Oliveira, Luciana Vieira Carvalho, Denise Vilarinho Tambourgi, Elisabeth Christina Nunes Tenório, Marisa Rizzi, Juliana Mussalem, Márcia Carvalho de Abreu Fantini, Viviane Fongaro Botosso, Osvaldo Augusto Sant´Anna. Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccineEinstein (São Paulo) 2011; 9(4): 436 doi: 10.1590/s1679-45082011ao2162
15
Fengchao Xu, Hongxiao Song, Beiying An, Qingfei Xiao, Genhong Cheng, Guangyun Tan. NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus ReplicationFrontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02382
16
Kyung-Yil Lee. Pediatric respiratory infections byMycoplasma pneumoniaeExpert Review of Anti-infective Therapy 2008; 6(4): 509 doi: 10.1586/14787210.6.4.509
17
Richard S Tedder, Sara L Bissett, Richard Myers, Samreen Ijaz. The ‘Red Queen’ Dilemma – Running to Stay in the Same Place: Refections on the Evolutionary Vector of HBV in HumansAntiviral Therapy 2013; 18(3_part_2): 489 doi: 10.3851/IMP2655
18
C.‐Thomas Bock, Joseph Torresi, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. Closing the door on hepatitis B†Hepatology 2008; 48(1): 338 doi: 10.1002/hep.22447
19
Yu-Fang Chen, Chin-Liew Chong, Yi-Chieh Wu, Yi-Ling Wang, Kuen-Nan Tsai, Tzer-Min Kuo, Ming-Hsiang Hong, Cheng-po Hu, Mong-Liang Chen, Yu-Chi Chou, Chungming Chang, Ming-Lung Yu. Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα ExpressionPLOS ONE 2015; 10(6): e0131743 doi: 10.1371/journal.pone.0131743
20
Surya Agung Priyambada, Ryo Misaki, Toru Okamoto, Yuta Okamoto, Takao Ohashi, Keiji Ueda, Yoshiharu Matsuura, Kazuhito Fujiyama. Cell surface N-glycan alteration in HepAD38 cell lines expressing Hepatitis B virusVirus Research 2017; 238: 101 doi: 10.1016/j.virusres.2017.06.003
21
Emmet B. Keeffe, Douglas T. Dieterich, Jean–Michel Pawlotsky, Yves Benhamou. Chronic Hepatitis B: Preventing, Detecting, and Managing Viral ResistanceClinical Gastroenterology and Hepatology 2008; 6(3): 268 doi: 10.1016/j.cgh.2007.12.043
22
Hui Feng, Jürgen Beck, Michael Nassal, Kang-hong Hu, Wang-Shick Ryu. A SELEX-Screened Aptamer of Human Hepatitis B Virus RNA Encapsidation Signal Suppresses Viral ReplicationPLoS ONE 2011; 6(11): e27862 doi: 10.1371/journal.pone.0027862
23
Christiane Guguen-Guillouzo, Andre Guillouzo. HepatocytesMethods in Molecular Biology 2010; 640: 1 doi: 10.1007/978-1-60761-688-7_1
24
Mehmet Sami Serin, Ebru Bekiroglu, Serpil Polat, Aylin Dogen, Seda Tezcan, Gonul Aslan, Orhan Sezgin, Engin Altintas, Gurol Emekdas, Enver Ucbilek. Detection of hepatitis B virus polymerase gene variants associated with Lamivudine, Adefovir and Entecavir resistance and some undefined mutations isolated from chronic hepatitis B patients in the south of TurkeyMolecular Genetics, Microbiology and Virology 2010; 25(4): 178 doi: 10.3103/S0891416810040075
25
AM Thabit, KA Al-Moyed, MS Al-Balushi, SS Hasson, TA Sallam. Occult hepatitis B virus among chronic liver disease patients in YemenAsian Pacific Journal of Tropical Disease 2012; 2(1): 4 doi: 10.1016/S2222-1808(12)60002-4
26
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinomaMicrobial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
27
Marcy Coash, George Y. Wu. Chronic Viral Hepatitis2009; : 1 doi: 10.1007/978-1-59745-565-7_1
28
Guangyun Tan, Hongxiao Song, Fengchao Xu, Genhong Cheng. When Hepatitis B Virus Meets InterferonsFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01611
29
Alexandra Alexopoulou, Larisa Vasilieva, Peter Karayiannis. New Approaches to the Treatment of Chronic Hepatitis BJournal of Clinical Medicine 2020; 9(10): 3187 doi: 10.3390/jcm9103187
30
Hong Tang, Mei-Fang Han, Ji-Ming Zhang. Acute Exacerbation of Chronic Hepatitis B2019; : 119 doi: 10.1007/978-94-024-1606-0_3